An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
An Open-Label, Proof-Of-Concept, Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
Epistemonikos ID: c79b9ede76a77a5bcf10e2a288946f87b35cd9c5
First added on: May 20, 2024